Glucagonoma CT: Difference between revisions
Jump to navigation
Jump to search
Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Findings on abdominal CT scan suggestive of glucagonoma include reinforced mass in the arterial phase of the enhanced CT scan.<ref name="pmid25789004">{{cite journal| author=Lv WF, Han JK, Liu X, Wang SC, Pan BO, Xu AO| title=Imaging features of glucagonoma syndrome: A case report and review of the literature. | journal=Oncol Lett | year= 2015 | volume= 9 | issue= 4 | pages= 1579-1582 | pmid=25789004 | doi=10.3892/ol.2015.2930 | pmc=PMC4356379 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25789004 }} </ref> | Findings on abdominal CT scan suggestive of glucagonoma include a reinforced mass in the arterial phase of the enhanced CT scan.<ref name="pmid25789004">{{cite journal| author=Lv WF, Han JK, Liu X, Wang SC, Pan BO, Xu AO| title=Imaging features of glucagonoma syndrome: A case report and review of the literature. | journal=Oncol Lett | year= 2015 | volume= 9 | issue= 4 | pages= 1579-1582 | pmid=25789004 | doi=10.3892/ol.2015.2930 | pmc=PMC4356379 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25789004 }} </ref> | ||
==CT== | ==CT== | ||
*Findings on abdominal CT scan suggestive of glucagonoma include reinforced mass in the arterial phase of the enhanced CT scan.<ref name="pmid25789004">{{cite journal| author=Lv WF, Han JK, Liu X, Wang SC, Pan BO, Xu AO| title=Imaging features of glucagonoma syndrome: A case report and review of the literature. | journal=Oncol Lett | year= 2015 | volume= 9 | issue= 4 | pages= 1579-1582 | pmid=25789004 | doi=10.3892/ol.2015.2930 | pmc=PMC4356379 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25789004 }} </ref> | *Findings on abdominal CT scan suggestive of glucagonoma include reinforced mass in the arterial phase of the enhanced CT scan.<ref name="pmid25789004">{{cite journal| author=Lv WF, Han JK, Liu X, Wang SC, Pan BO, Xu AO| title=Imaging features of glucagonoma syndrome: A case report and review of the literature. | journal=Oncol Lett | year= 2015 | volume= 9 | issue= 4 | pages= 1579-1582 | pmid=25789004 | doi=10.3892/ol.2015.2930 | pmc=PMC4356379 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25789004 }} </ref> |
Revision as of 15:38, 16 October 2015
Glucagonoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Glucagonoma CT On the Web |
American Roentgen Ray Society Images of Glucagonoma CT |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Findings on abdominal CT scan suggestive of glucagonoma include a reinforced mass in the arterial phase of the enhanced CT scan.[1]
CT
- Findings on abdominal CT scan suggestive of glucagonoma include reinforced mass in the arterial phase of the enhanced CT scan.[1]
- CT scans confirm the location of the tumor and show the organs nearby. These are helpful for determining the stage of the cancer and in determining whether surgery is a good treatment option.
-
A 3-cm nodular mass in the head of the pancreas[2]
-
Computed tomography scan of the abdomen showing a large tumor in the tail of the pancreas[3]
References
- ↑ 1.0 1.1 Lv WF, Han JK, Liu X, Wang SC, Pan BO, Xu AO (2015). "Imaging features of glucagonoma syndrome: A case report and review of the literature". Oncol Lett. 9 (4): 1579–1582. doi:10.3892/ol.2015.2930. PMC 4356379. PMID 25789004.
- ↑ Wu SL, Bai JG, Xu J, Ma QY, Wu Z (2014). "Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor". World J Surg Oncol. 12: 220. doi:10.1186/1477-7819-12-220. PMC 4105234. PMID 25029913.
- ↑ Fang S, Li S, Cai T (2014). "Glucagonoma syndrome: a case report with focus on skin disorders". Onco Targets Ther. 7: 1449–53. doi:10.2147/OTT.S66285. PMC 4140234. PMID 25152626.